EGFR and non-small cell lung carcinoma: Erlotinib (Tarceva®, OSI-774, R1415, CP358774, NSC718781) is a reversible small molecule ATP-competing inhibitor of EGFR primarily used to treat non-small cell lung cancer (NSCLC) [30].